Characterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8
about
Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cellsCarboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies.Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus.Complex alternative cytoplasmic protein isoforms of the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 generated through noncanonical translation initiation.Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes.Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures.Effective human herpesvirus 8 infection of human umbilical vein endothelial cells by cell-mediated transmission.DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirusDetection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA.Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirusPathology of Kaposi's Sarcoma-Associated Herpesvirus InfectionKSHV/HHV-8 associated Kaposi's sarcoma in lymph nodes concurrent with Epstein-Barr virus associated Hodgkin lymphomaDifferential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNAWild-type Kaposi's sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells.NF-κB as a target for oncogenic viruses.Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X ComplexInternal ribosome entry site regulates translation of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein.Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas.Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.Detection of KSHV in transbronchial biopsies in patients with Kaposi sarcoma.Kaposi's sarcoma associated herpesvirus in a rural Ugandan cohort: 1992-2008.KSHV LANA upregulates the expression of epidermal growth factor like domain 7 to promote angiogenesis.Superresolution microscopy reveals structural mechanisms driving the nanoarchitecture of a viral chromatin tether.In vivo persistence of chimeric virus after substitution of the KSHV LANA DNA binding domain with that of MuHV-4
P2860
Q24527215-19497E56-7208-4210-96C4-0569C99B8AB4Q24531182-23F4EA32-BE6C-44FC-90FE-F5B3DB146FC2Q30311122-CF01086A-A65F-4436-868C-E590F8170629Q30535717-BDB270CD-7C67-473E-933C-02DA21F3E750Q33683742-2394BDC4-F279-41B4-8D23-5C1FDEE5929CQ33772234-01116DD2-34A9-49FB-BF51-BA5C82F85BFBQ33841987-F6256898-CF50-4DF7-B997-44ED0A9FC4DDQ33853082-FCEC2AC2-7065-4365-B26C-8983984ED850Q33853499-1E153D01-9061-4DBB-BC9B-6AE71637E510Q34309014-D150E49C-09F3-40EA-92F4-93CF405F9705Q34333321-77F363B8-8352-4025-A47A-D1FC10C3812AQ35179783-8F60E539-640C-443D-82B4-1A5C5F06CB29Q35588588-0832035B-D98B-4F6C-AB72-915194BE4225Q35809792-5B3810B5-1E40-4AC2-934F-20DD0CDE7036Q36086767-51042EE9-B19A-4713-A3DD-070BD841E328Q37092875-7764AB30-4BB6-4CD2-8E9C-7CA2A4829E24Q37374081-AD2000AC-4DE7-4194-8A64-900747545D7EQ38903379-44D59E3D-A60D-4020-AE0A-6BE9FFED1A60Q39610285-7504FEE0-1B20-428D-A13F-11A90B2B5317Q39744147-00CA5538-EC10-4825-A331-595A551BC57AQ41924146-C160D411-FE94-4E9C-868B-899DB5DDC4F1Q42330651-3321AE62-F916-4FB4-8950-E6D00505F33BQ46331744-E195E708-D763-42C6-BC36-E1BA86AB92BDQ49363063-5C8F2355-8362-4D8F-AE15-F39AA98A34D2Q52722164-95B4278F-4D89-4710-B46E-073E51EC1063Q57909946-EC45C2BC-EC70-472A-AFE3-E17D80CFD443
P2860
Characterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Characterization of monoclonal ...... antigen of human herpesvirus 8
@ast
Characterization of monoclonal ...... antigen of human herpesvirus 8
@en
type
label
Characterization of monoclonal ...... antigen of human herpesvirus 8
@ast
Characterization of monoclonal ...... antigen of human herpesvirus 8
@en
prefLabel
Characterization of monoclonal ...... antigen of human herpesvirus 8
@ast
Characterization of monoclonal ...... antigen of human herpesvirus 8
@en
P2093
P2860
P1433
P1476
Characterization of monoclonal ...... antigen of human herpesvirus 8
@en
P2093
Bourboulia D
P2860
P304
P577
1999-06-01T00:00:00Z